<VariationArchive VariationID="1780822" VariationName="NM_001172509.2(SATB2):c.1825_1826dup (p.Asp609fs)" VariationType="Duplication" Accession="VCV001780822" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-01" DateCreated="2022-11-29" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1832117" VariationID="1780822">
      <GeneList>
        <Gene Symbol="LOC126806462" FullName="MED14-independent group 3 enhancer GRCh37_chr2:200136608-200137807" GeneID="126806462" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="199271885" stop="199273084" display_start="199271885" display_stop="199273084" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SATB2" FullName="SATB homeobox 2" GeneID="23314" HGNC_ID="HGNC:21637" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="199269500" stop="199471266" display_start="199269500" display_stop="199471266" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="200134222" stop="200335988" display_start="200134222" display_stop="200335988" Strand="-" />
          </Location>
          <OMIM>608148</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SATB2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SATB2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001172509.2(SATB2):c.1825_1826dup (p.Asp609fs)</Name>
      <CanonicalSPDI>NC_000002.12:199272586:TCT:TCTCT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q33.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="199272586" stop="199272587" display_start="199272586" display_stop="199272587" variantLength="2" positionVCF="199272586" referenceAlleleVCF="G" alternateAlleleVCF="GTC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="200137309" stop="200137310" display_start="200137309" display_stop="200137310" variantLength="2" positionVCF="200137309" referenceAlleleVCF="G" alternateAlleleVCF="GTC" />
      </Location>
      <ProteinChange>D609fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.200137311_200137312dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.200137311_200137312dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.199272588_199272589dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.199272588_199272589dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016976.2" sequenceAccession="NG_016976" sequenceVersion="2" change="g.203679_203680dup">
            <Expression>NG_016976.2:g.203679_203680dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_082782.1" sequenceAccession="NG_082782" sequenceVersion="1" change="g.804_805dup">
            <Expression>NG_082782.1:g.804_805dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172509.2" sequenceAccession="NM_001172509" sequenceVersion="2" change="c.1825_1826dup" MANESelect="true">
            <Expression>NM_001172509.2:c.1825_1826dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165980.1" sequenceAccession="NP_001165980" sequenceVersion="1" change="p.Asp609fs">
            <Expression>NP_001165980.1:p.Asp609fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172517.1" sequenceAccession="NM_001172517" sequenceVersion="1" change="c.1825_1826dup">
            <Expression>NM_001172517.1:c.1825_1826dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165988.1" sequenceAccession="NP_001165988" sequenceVersion="1" change="p.Asp609fs">
            <Expression>NP_001165988.1:p.Asp609fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015265.4" sequenceAccession="NM_015265" sequenceVersion="4" change="c.1825_1826dup">
            <Expression>NM_015265.4:c.1825_1826dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056080.1" sequenceAccession="NP_056080" sequenceVersion="1" change="p.Asp609fs">
            <Expression>NP_056080.1:p.Asp609fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001172509.2(SATB2):c.1825_1826dup (p.Asp609fs) AND Inborn genetic diseases" Accession="RCV002410415" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-01-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-01-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-11-29" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12915443</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18187506</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21089028</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25885067</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27409069</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27462121</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28151491</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29436146</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5201605" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a452246|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002710523" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12915443</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18187506</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21089028</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25885067</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27409069</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27462121</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28151491</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29436146</ID>
          </Citation>
          <Comment>The c.1825_1826dupGA pathogenic mutation, located in coding exon 10 of the SATB2 gene, results from a duplication of GA at nucleotide position 1825, causing a translational frameshift with a predicted alternate stop codon (p.D609Efs*16). This alteration is expected to result in loss of function by premature protein truncation. In addition, multiple other frameshift and nonsense alterations in coding exon 10 have been reported in individuals with SATB2-related neurodevelopmental disorders; commonly reported clinical features in these cases include: developmental delay/intellectual disability, absent speech, high or cleft palate, abnormal dentition, skeletal findings (low bone density, fractures, scoliosis), and/or happy/jovial personality (Zarate YA et al. Am. J. Med. Genet. A, 2015 May;167A:1026-32; Boone PM et al. Am. J. Med. Genet. A, 2016 11;170:3028-3032; Bengani H et al. Genet. Med., 2017 08;19:900-908; Zarate YA et al. Am. J. Med. Genet. A, 2018 04;176:925-935). Also, this duplication is predicted to result in loss of the homeodomain which is conserved among different species and between SATB1 and SATB2 (FitzPatrick DR et al. Hum. Mol. Genet., 2003 Oct;12:2491-501; Sheehan-Rooney K et al. Dev. Dyn., 2010 Dec;239:3481-91); the highly similar homeodomain in SATB1 has been demostrated to bind DNAs, indicating that this domain is important for protein function (Purbey PK et al. Nucleic Acids Res., 2008 Apr;36:2107-22; Yamasaki K et al. Biochem. J., 2016 10;473:3321-39). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SATB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015265.3:c.1825_1826dupGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5201605" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

